- Home
- SEAT vs HUMA Comparison
SEAT vs HUMA Comparison
Compare SEAT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEAT
- HUMA
- Stock Information
- Founded
- SEAT 2001
- HUMA 2004
- Country
- SEAT United States
- HUMA United States
- Employees
- SEAT N/A
- HUMA N/A
- Industry
- SEAT Industrial Machinery/Components
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- SEAT Industrials
- HUMA Health Care
- Exchange
- SEAT Nasdaq
- HUMA Nasdaq
- Market Cap
- SEAT 96.5M
- HUMA 250.2M
- IPO Year
- SEAT N/A
- HUMA N/A
- Fundamental
- Price
- SEAT $17.02
- HUMA $1.47
- Analyst Decision
- SEAT Buy
- HUMA Strong Buy
- Analyst Count
- SEAT 11
- HUMA 8
- Target Price
- SEAT $68.00
- HUMA $10.88
- AVG Volume (30 Days)
- SEAT 122.1K
- HUMA 3.4M
- Earning Date
- SEAT 11-06-2025
- HUMA 11-07-2025
- Dividend Yield
- SEAT N/A
- HUMA N/A
- EPS Growth
- SEAT N/A
- HUMA N/A
- EPS
- SEAT N/A
- HUMA N/A
- Revenue
- SEAT $694,007,000.00
- HUMA $818,000.00
- Revenue This Year
- SEAT N/A
- HUMA N/A
- Revenue Next Year
- SEAT N/A
- HUMA $949.92
- P/E Ratio
- SEAT N/A
- HUMA N/A
- Revenue Growth
- SEAT N/A
- HUMA N/A
- 52 Week Low
- SEAT $14.54
- HUMA $1.15
- 52 Week High
- SEAT $100.00
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- SEAT 42.67
- HUMA 37.20
- Support Level
- SEAT $14.69
- HUMA $1.38
- Resistance Level
- SEAT $16.71
- HUMA $1.53
- Average True Range (ATR)
- SEAT 1.17
- HUMA 0.09
- MACD
- SEAT 0.65
- HUMA 0.02
- Stochastic Oscillator
- SEAT 69.80
- HUMA 31.03
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.